These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 6441959)

  • 41. No effect from double-blind trial of physostigmine and lecithin in Alzheimer disease.
    Wettstein A
    Ann Neurol; 1983 Feb; 13(2):210-2. PubMed ID: 6830183
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of xantinolnicotinate in patients with dementia.
    Kanowski S; Fischhof PK; Grobe-Einsler R; Wagner G; Litschauer G
    Pharmacopsychiatry; 1990 May; 23(3):118-24. PubMed ID: 2197635
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oral physostigmine treatment for patients with presenile and senile dementia of the Alzheimer's type: a double-blind placebo-controlled trial.
    Jenike MA; Albert MS; Heller H; Gunther J; Goff D
    J Clin Psychiatry; 1990 Jan; 51(1):3-7. PubMed ID: 2403997
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased glutathione peroxidase activity in erythrocytes in patients with Alzheimer's disease/senile dementia of Alzheimer's type.
    Annerén G; Gardner A; Lundin T
    Acta Neurol Scand; 1986 Jun; 73(6):586-9. PubMed ID: 3751499
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
    Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Memantine for dementia.
    Areosa Sastre A; McShane R; Sherriff F
    Cochrane Database Syst Rev; 2004 Oct; (4):CD003154. PubMed ID: 15495043
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multiple actions of THA on cholinergic neurotransmission in Alzheimer brains.
    Nordberg A; Nilsson-Håkansson L; Adem A; Lai Z; Winblad B
    Prog Clin Biol Res; 1989; 317():1169-78. PubMed ID: 2557636
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The use of 1-acetylcarnitine in (presenile and senile) Alzheimer's disease. Preliminary results].
    Acierno G
    Clin Ter; 1983 Apr; 105(2):135-45. PubMed ID: 6345054
    [No Abstract]   [Full Text] [Related]  

  • 49. Membrane components separate early-onset Alzheimer's disease from senile dementia of the Alzheimer type.
    Gottfries CG; Karlsson I; Svennerholm L
    Int Psychogeriatr; 1996; 8(3):365-72. PubMed ID: 9116173
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cholinergic drugs, affective disorders and dementia: problems of clinical research.
    Spiegel R
    Acta Psychiatr Scand Suppl; 1991; 366():66-9. PubMed ID: 1897378
    [No Abstract]   [Full Text] [Related]  

  • 51. Prescribing practice with cognition enhancers in outpatient care: are there differences regarding type of dementia?--Results of a representative survey in lower Saxony, Germany.
    Stoppe G; Sandholzer H; Staedt J; Winter S; Kiefer J; Rüther E
    Pharmacopsychiatry; 1996 Jul; 29(4):150-5. PubMed ID: 8858714
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Double-blind study with phosphatidylserine (PS) in parkinsonian patients with senile dementia of Alzheimer's type (SDAT).
    Fünfgeld EW; Baggen M; Nedwidek P; Richstein B; Mistlberger G
    Prog Clin Biol Res; 1989; 317():1235-46. PubMed ID: 2690093
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhancement of memory processes in Alzheimer's disease with multiple-dose intravenous physostigmine.
    Davis KL; Mohs RC
    Am J Psychiatry; 1982 Nov; 139(11):1421-4. PubMed ID: 6753611
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multicentre study of l-alpha-glyceryl-phosphorylcholine vs ST200 among patients with probable senile dementia of Alzheimer's type.
    Parnetti L; Abate G; Bartorelli L; Cucinotta D; Cuzzupoli M; Maggioni M; Villardita C; Senin U
    Drugs Aging; 1993; 3(2):159-64. PubMed ID: 8477148
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quantitative EEG in patients with presenile and senile dementia of the Alzheimer type.
    Miyauchi T; Hagimoto H; Ishii M; Endo S; Tanaka K; Kajiwara S; Endo K; Kajiwara A; Kosaka K
    Acta Neurol Scand; 1994 Jan; 89(1):56-64. PubMed ID: 8178630
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cholinergic drugs as diagnostic and therapeutic tools in affective disorders.
    Berger M; Riemann D; Krieg C
    Acta Psychiatr Scand Suppl; 1991; 366():52-60. PubMed ID: 1897376
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Galantamine for Alzheimer's disease.
    Olin J; Schneider L
    Cochrane Database Syst Rev; 2001; (1):CD001747. PubMed ID: 11279727
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of physostigmine and lecithin on memory in Alzheimer disease.
    Peters BH; Levin HS
    Ann Neurol; 1979 Sep; 6(3):219-21. PubMed ID: 534419
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intraventricular bethanechol infusion for Alzheimer's disease: results of double-blind and escalating-dose trials.
    Penn RD; Martin EM; Wilson RS; Fox JH; Savoy SM
    Neurology; 1988 Feb; 38(2):219-22. PubMed ID: 2893314
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cortical substance P-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type.
    Crystal HA; Davies P
    J Neurochem; 1982 Jun; 38(6):1781-4. PubMed ID: 6176686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.